AB — AB Science SA Share News
0.000.00%
Last trade - 00:00- €65.08m
- €73.85m
- €1.17m
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041
Brief: AB Science Phase 1 AML Study Of AB8939 Shows 100% Partial Response Rate
Brief: AB Science Receives Notice Of Allowance For European Patent Covering Masitinib Until 2040 In Treatment Of Sickle Cell Disease
Brief: AB Science SA Says EMA Confirmed Negative Opinion For Conditional Marketing Authorization Of Masitinib
Brief: AB Science Provides Update On Application For Conditional Marketing Authorisation Of Masitinib In ALS
Brief: AB Science SA Says Consolidated Operating Loss Of EUR 13.4 Million As Of 31 December 2023, Compared With A Loss Of EUR 15.9 Million As Of 31 December 2022
Brief: AB Science Announces Issuance Of European Patent For Masitinib
Brief: AB Science SA Says Paris Court Of Appeal Confirms Acquittal Of CEO Of Co, Alain Moussy, And Reduces Amount Of Financial Penalty Imposed On AB Science
Brief: AB Science: Health Canada Grants Eligibility For Reconsideration Request For Masitinib
Brief: AB Science Shares New Research Results On Masitinib
Brief: AB Science Says Health Canada Issued Notice Of Non-Compliance-Withdrawal For Masitinib In ALS
Brief: AB Science Announces Update In Marketing Authorization Application Of Masitinib
Brief: AB Science Receives Notice Of Allowance For European Patent Covering Masitinib Until 2036
Brief: AB Science: Masitinib Clinical Development In Sickle Cell Disease Among 19 Winning Projects Under RHU
Brief: AB Science Reports Operating Loss Of Eur 8.9 Mln As Of 30 June 2023, Decrease Of 7.5% Compared To First Half 2022
Brief: AB Science-Update On EMA Timetable For Masitinib Marketing Authorization
Factbox: Companies in Alzheimer's race after US nod for Eisai/Biogen drug
Brief: AB Science Receives Notice Of Allowance For European Patent Covering Masitinib In Treatment Of Metastatic Castrate Refractory Prostate Cancer